Maven Securities »

Ultragenyx Pharmaceutical shares owned by Maven Securities

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Maven Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $822k 20k 41.10
2024-03-31 $467k 10k 46.69

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Call Call Option
United States Stl Corp Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Put Put Option
United States Stl Corp Call Call Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Capri Holdings Call Call Option
Capri Holdings Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Ishares Tr Call Call Option
Select Sector Spdr Tr Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Call Call Option

View all positions for Maven Securities

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
BlackRock
Sands Capital Management
T. Rowe Price Associates
State Street Corporation
ClearBridge Advisors
Federated Investors
Suvretta Capital Management
Rock Springs Capital Management
Deutsche Bank Aktiengesellschaft
Invesco
Baker Bros. Advisors
Geode Capital Management
Alliancebernstein

View all funds holding Ultragenyx Pharmaceutical